Cargando…

Lichen planus after SARS-CoV-2 infection treated with lopinavir/ritonavir()

Detalles Bibliográficos
Autores principales:	Gimeno Castillo, Javier, de la Torre Gomar, Francisco Javier, Saenz Aguirre, Amaia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier España, S.L.U. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980180/ https://www.ncbi.nlm.nih.gov/pubmed/33778159 http://dx.doi.org/10.1016/j.medcle.2020.12.014

Ejemplares similares

Liquen plano en una paciente tras SARS-CoV-2 tratado con lopinavir/ritonavir
por: Gimeno Castillo, Javier, et al.
Publicado: (2021)

Lopinavir/ritonavir: Lichen planus following off-label use: case report
Publicado: (2021)

Maculopapular rash in COVID-19 patient treated with lopinavir/ritonavir
por: Mazan, Paula, et al.
Publicado: (2020)

HCV and lichen planus: HCV and lichen planus
por: Rebora, Alfredo
Publicado: (2011)

Serotonin syndrome in two COVID-19 patients treated with lopinavir/ritonavir
por: Mas Serrano, Miguel, et al.
Publicado: (2020)

Dimethyl Fumarate as Therapeutic Alternative in Moderate-to-Severe Psoriasis: Our Experience
por: Rosés Gibert, Pau, et al.
Publicado: (2022)

Remdesivir versus ritonavir/lopinavir in COVID-19 patients
por: Vitiello, Antonio, et al.
Publicado: (2020)

The administration of lopinavir/ritonavir via an enteral feeding tube()
por: Sirvent Segovia, Alejandro Esteban, et al.
Publicado: (2021)

Bullous Lichen Planus vs Lichen Planus Pemphigoides: A Diagnostic Dilemma
por: Tripathy, Durga M., et al.
Publicado: (2022)

Association between hepatitis C virus and oral lichen planus: HCV and oral Lichen Planus
por: Oliveira Alves, Mônica Ghislaine, et al.
Publicado: (2011)

A severe COVID-19 despite ongoing treatment with Lopinavir-Ritonavir
por: Joumaa, H., et al.
Publicado: (2020)

An open-label randomized, controlled trial of the effect of lopinavir and ritonavir, lopinavir and ritonavir plus interferon-β-1a, and hydroxychloroquine in hospitalized patients with COVID-19: final results
por: Ader, Florence
Publicado: (2022)

Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19
por: Zhu, Zhen, et al.
Publicado: (2020)

Ritonavir- and lopinavir-induced eryptosis in a SARS-CoV-2–infected patient
por: Stalder, Gregoire, et al.
Publicado: (2020)

Lopinavir/ritonavir monotherapy in clinical practice
por: Caso, A, et al.
Publicado: (2010)

Lopinavir-Ritonavir-Kombination nicht wirksam
por: Diener, Hans-Christoph
Publicado: (2020)

Lack of viral clearance by the combination of hydroxychloroquine and azithromycin or lopinavir and ritonavir in SARS-CoV-2-related acute respiratory distress syndrome
por: Hraiech, Sami, et al.
Publicado: (2020)

Crushing lopinavir/ritonavir tablets does not result in lower exposure to lopinavir/ritonavir in adult patients with COVID-19
por: Mohsenian Naghani, Shaghayegh, et al.
Publicado: (2023)

Early administration of ritonavir-boosted lopinavir could prevent severe COVID-19
por: Klement-Frutos, Elise, et al.
Publicado: (2021)

Lopinavir-Ritonavir in SARS-CoV-2 Infection and Drug-Drug Interactions with Cardioactive Medications
por: Agarwal, Shubham, et al.
Publicado: (2020)

Safety profile of the lopinavir/ritonavir combination before and during the SARS-CoV-2 pandemic
por: Lory, Pauline, et al.
Publicado: (2022)

Coexistence of nail lichen planus and lichen planus pigmentosus
por: Lemes, Luciana Rodino, et al.
Publicado: (2016)

Propofol/lopinavir/ritonavir: Bradyarrythmia: case report
Publicado: (2020)

Bullous oral lichen planus: An unusual variant
por: Jindal, Rashmi, et al.
Publicado: (2011)

Colocalization of linear lichen planus and psoriasis vulgaris
por: Gutte, Rameshwar Madhukarrao
Publicado: (2016)

Lichen planus hypertrophicus of the vulva – An isolated presentation
por: Poonia, Kavita, et al.
Publicado: (2022)

Lichen Planus
por: Boch, Katharina, et al.
Publicado: (2021)

Acral lesions in a pediatric population during the COVID-19 pandemic: a case series of 36 patients from a single hospital in Spain
por: Rosés-Gibert, Pau, et al.
Publicado: (2020)

Three Novel COVID-19 Pneumonia Cases Successfully Treated With Lopinavir/Ritonavir
por: Wada, Tatsuhiko, et al.
Publicado: (2020)

Prediction of lopinavir/ritonavir effectiveness in COVID-19 patients: a recall of basic pharmacology concepts
por: Cattaneo, Dario, et al.
Publicado: (2020)

Administración de lopinavir/ritonavir a través de sonda de nutrición enteral
por: Sirvent Segovia, Alejandro Esteban, et al.
Publicado: (2021)

Early Lopinavir/ritonavir does not reduce mortality in COVID-19 patients: Results of a large multicenter study
por: Lora-Tamayo, Jaime, et al.
Publicado: (2021)

Modulations of human placental transfer of lopinavir, ritonavir and enfuvirtide
por: Ceccaldi, Pierre-François, et al.
Publicado: (2010)

Population pharmacokinetics of lopinavir/ritonavir in Covid-19 patients
por: Alvarez, Jean Claude, et al.
Publicado: (2020)

Lopinavir/ritonavir: vomiting and watery diarrhoea: case report
Publicado: (2020)

Risk of bradycardia with lopinavir/ritonavir in COVID-19 patients
Publicado: (2020)

Lichen planus pemphigoides successfully treated with dupilumab
por: Ch’en, Peter Yi, et al.
Publicado: (2022)

Differential diagnosis between pemphigoid and erosive lichen planus
por: Cheng, Zhe, et al.
Publicado: (2022)

Genital lichen planus: Adding to the review of an “underrecognized entity”
por: Sonthalia, Sidharth, et al.
Publicado: (2022)

Co-Existing Alopecia Areata, Lichen Planus, and Lichen Planopilaris: A Rare Occurrence
por: Kothari, Rohit, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u5mijto7b8ksc7g5t0fp8093rv